Preliminary safety, efficacy, pharmacokinetics, and pharmacodynamics of subcutaneously (SC) administered PF-06863135, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM) Meeting Abstract
| Authors: | Lesokhin, A. M.; Levy, M. Y.; Dalovisio, A. P.; Bahlis, N. J.; Solh, M.; Sebag, M.; Jakubowiak, A.; Jethava, Y. S.; Costello, C. L.; Chu, M. P.; Savona, M. R.; Gasparetto, C.; Trudel, S.; Chou, J.; Udata, C.; Basu, C.; Krupka, H. I.; Raje, N. S. |
| Abstract Title: | Preliminary safety, efficacy, pharmacokinetics, and pharmacodynamics of subcutaneously (SC) administered PF-06863135, a B-cell maturation antigen (BCMA)-CD3 bispecific antibody, in patients with relapsed/refractory multiple myeloma (RRMM) |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| ACCESSION: | WOS:000607547202145 |
| DOI: | 10.1182/blood-2020-133355 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 8 -- Source: Wos |
